Clinical Trial Update: Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial compares high-dose rosuvastatin with low-dose statin plus fenofibrate, and low-dose statin plus niacin for mixed dyslipidemia; the u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Niacin (nicotinic acid)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: University of Ioannina | Conditions: Dyslipidemia | Phase 4 | Status: UNKNOWN